Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma
出版年份 2015 全文链接
标题
Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma
作者
关键词
SIRT1, Esophageal squamous cell carcinoma, Overall survival, Prognostic factor
出版物
TUMOR BIOLOGY
Volume 37, Issue 6, Pages 7139-7148
出版商
Springer Nature
发表日期
2015-12-12
DOI
10.1007/s13277-015-4459-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
- (2015) Chong Li et al. OncoTargets and Therapy
- SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer
- (2014) Akira Noguchi et al. Cancer Medicine
- Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption
- (2013) Nirmala Pandeya et al. Cancer Epidemiology
- SIRT1 Expression Is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC
- (2013) Tao Zhang et al. PLoS One
- SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of β-catenin
- (2012) Il-Rae Cho et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
- (2012) Chu-Xia Deng International Journal of Biological Sciences
- Aberrant Cytoplasm Localization and Protein Stability of SIRT1 is Regulated by PI3K/IGF-1R Signaling in Human Cancer Cells
- (2012) Vanessa Byles et al. International Journal of Biological Sciences
- SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling
- (2012) Guoan Xiang ONCOLOGY REPORTS
- Effects of Niacin Restriction on Sirtuin and PARP Responses to Photodamage in Human Skin
- (2012) Claudia A. Benavente et al. PLoS One
- Sirtuins and Disease: The Road Ahead
- (2012) Vincenzo Carafa et al. Frontiers in Pharmacology
- Transcription factor FOXL2 protects granulosa cells from stress and delays cell cycle: role of its regulation by the SIRT1 deacetylase
- (2011) Bérénice A. Benayoun et al. HUMAN MOLECULAR GENETICS
- Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma
- (2010) Ho Lee et al. HUMAN PATHOLOGY
- Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1
- (2010) W. K. Oh et al. MOLECULAR PHARMACOLOGY
- The Critical Role of the Class III Histone Deacetylase SIRT1 in Cancer
- (2009) T. Liu et al. CANCER RESEARCH
- Sirtuin inhibitors
- (2009) Francisco J Alcaín et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator
- (2008) Sonia Lain et al. CANCER CELL
- Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
- (2008) Rui-Hong Wang et al. CANCER CELL
- Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis
- (2008) Rui-Hong Wang et al. MOLECULAR CELL
- Sirtuins — novel therapeutic targets to treat age-associated diseases
- (2008) Siva Lavu et al. NATURE REVIEWS DRUG DISCOVERY
- The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth
- (2008) Ron Firestein et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now